Skip to main content
SpringerLink
Log in

Cerebral Ischemia: Pathophysiology, Diagnosis, and Management

  • Chapter
  • First Online:
Metabolic Disorders and Critically Ill Patients

  • 1807 Accesses

Abstract

In industrialized countries, stroke represents the third cause of death after cardiopathies and cancers, and the first cause of long-term disability in adults [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Feigin VL, Lawes CM, Bennett DA, Anderson CS (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43–53

    Article  PubMed  Google Scholar 

  2. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344:1450–1460

    Article  CAS  PubMed  Google Scholar 

  3. Hossman KA (2006) Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 26:1057–1083

    Article  Google Scholar 

  4. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA et al (2008) Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab 28:412–419

    Article  PubMed  Google Scholar 

  5. Bandera E, Botteri M, Minelli C, Sutton A, Abrams KR, Latronico N (2006) Cerebral blood flow threshold of ischemic penumbra and infarct core in acute ischemic stroke: a systematic review. Stroke 37:1334–1339

    Article  PubMed  Google Scholar 

  6. Cunningham AS, Salvador R, Coles JP et al (2005) Physiological thresholds for irreversible tissue damage in contusional regions following traumatic brain injury. Brain 128:1931–1942

    Article  CAS  PubMed  Google Scholar 

  7. Coles JP, Cunningham AS, Salvador R, Chatfield DA, Carpenter A, Pickard JD, Menon DK (2009) Early metabolic characteristics of lesion and nonlesion tissue after head injury. J Cereb Blood Flow Metab 29:965–975

    Article  PubMed  Google Scholar 

  8. Leclerc X, Fichten A, Gauvrit JY, Riegel B, Steinling M, Lejeune JP et al (2002) Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography. Neuroradiology 44:610–616

    Article  CAS  PubMed  Google Scholar 

  9. Jabre A, Babikian V, Powsner RA, Spatz EL (2002) Role of single photon emission computed tomography and transcranial Doppler ultrasonography in clinical vasospasm. J Clin Neurosci 9:400–403

    Article  PubMed  Google Scholar 

  10. Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P (2003) Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 98:1227–1234

    Article  PubMed  Google Scholar 

  11. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22:391–397

    Article  CAS  PubMed  Google Scholar 

  12. Doyle KP, Simon RP, Stenzel-Poore MP (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55:310–318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Hata R, Maeda K, Hermann D, Mies G, Hossmann KA (2000) Evolution of brain infarction after transient focal cerebral ischemia in mice. J Cereb Blood Flow Metab 20:937–946

    Article  CAS  PubMed  Google Scholar 

  14. Olney JW (1986) Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 203:631–645

    Article  CAS  PubMed  Google Scholar 

  15. Benveniste H, Drejer J, Schousboe A, Diemer NH (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43:1369–1374

    Article  CAS  PubMed  Google Scholar 

  16. Graham SH, Shirashi K, Panter SS, Simon RP, Faden AI (1990) Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia. Neurosci Lett 110:124–130

    Article  CAS  PubMed  Google Scholar 

  17. Castillo J, Davalos A, Naveiro J, Noya M (1996) Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke. Stroke 27:1060–1065

    Article  CAS  PubMed  Google Scholar 

  18. Jehle T, Lagrèze WA, Blauth E, Knörle R, Schnierle P, Lücking CH, Feuerstein TJ (2000) Gabapentin-lactam (8-aza-spiro[5,4]decan-9-on; GBP-L) inhibits oxygen glucose deprivation-induced [3H]glutamate release and is a neuroprotective agent in a model of acute retinal ischemia. Naunyn Schmiedebergs Arch Pharmacol 362:74–81

    Article  CAS  PubMed  Google Scholar 

  19. Jabaudon D, Scanziani M, Gähwiler BH, Gerber U (2000) Acute decrease in net glutamate uptake during energy deprivation. Proc Natl Acad Sci U S A 97:5610–5615

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Neumar RW (2000) Molecular mechanisms of ischemic neuronal injury. Ann Emerg Med 36:483–506

    Article  CAS  PubMed  Google Scholar 

  21. Siesjo BK (1994) Calcium-mediated processes in neuronal degeneration. Ann N Y Acad Sci 747:140–161

    Article  CAS  PubMed  Google Scholar 

  22. Bonde C, Noraberg J, Noer H, Zimmer J (2005) Ionotropic glutamate receptors andglutamate transporters are involved in necrotic neuronal cell death induced by oxygen–glucose deprivation of hippocampal slice cultures. Neurosciences 136:779–794

    Article  CAS  Google Scholar 

  23. Pettigrew L, Holtz S, Craddocak S, Minger N, Geddes J (1996) Microtubular proteolysis in focal cerebral ischemia. J Cereb Blood Flow Metab 16:1189–1202

    Article  CAS  PubMed  Google Scholar 

  24. Zhang Y, Sun G (1995) Free fatty acids, neutral glycerides and phosphoglycerides in transient focal ischemia. J Neurochem 64:1688–1695

    Article  CAS  PubMed  Google Scholar 

  25. Sapirstein A, Bonventre JV (2000) Phospholipases A2 in ischemic and toxic brain injury. Neurochem Res 25:745–753

    Article  CAS  PubMed  Google Scholar 

  26. Solenski NJ, Kwan AL, Yanamoto H, Bennett JP, Kassell NF, Lee KS (1997) Differential hydroxylation of salicylate in core and penumbra regions during focal reversible cerebral ischemia. Stroke 28:2545–2552

    Article  CAS  PubMed  Google Scholar 

  27. Hallenbeck JM, Dutka AJ (1990) Background review and current concepts of reperfusion injury. Arch Neurol 47:1245–1254

    Article  CAS  PubMed  Google Scholar 

  28. Andreyev AY, Kushnareva YE, Starkov AA (2005) Mitochondrial metabolism of reactive oxygen species. Biochemistry 70:200–214

    CAS  PubMed  Google Scholar 

  29. Iadecola C (1997) Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132–139

    Article  CAS  PubMed  Google Scholar 

  30. Suh SW, Chen JW, Motamedi M, Bell B, Listiak K, Pons NF, Danscher G, Frederickson CJ (2000) Evidence that synoptically-released zinc contributes to neuronal injury after traumatic brain injury. Brain Res 852:268–273

    Article  CAS  PubMed  Google Scholar 

  31. O’Neill LA, Kaltschmidt C (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252–258

    Article  PubMed  Google Scholar 

  32. Frijns CJM, Kappelle LJ (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33:2115–2122

    Article  CAS  PubMed  Google Scholar 

  33. Nakka VP, Gusain A, Mehta SL, Raghubir R (2008) Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol 37:7–38

    Article  CAS  PubMed  Google Scholar 

  34. Badaut J, Lasbennes F, Magistretti PJ, Regli L (2002) Aquaporins in brain: distribution, physiology, and pathophysiology. J Cereb Blood Flow Metab 22:367–378

    Article  CAS  PubMed  Google Scholar 

  35. Badaut J, Brunet JF, Grollimund L et al (2003) Aquaporin 1 and 4 expression after human acute subarachnoid hemorrhage. Acta Neurochir 86:495–498

    CAS  Google Scholar 

  36. Unterberg AW, Stover J, Kress B, Kiening KL (2004) Edema and brain trauma. Neuroscience 129:1019–1027

    Article  Google Scholar 

  37. Payen JF, Fauvage B, Falcon D, Lavagne P (2003) Brain oedema following blood-brain barrier disruption: mechanisms and diagnosis. Ann Fr Anesth Reanim 22:220–225

    Article  CAS  PubMed  Google Scholar 

  38. Wang G, Huang H, He Y, Ruan L, Huang J (2014) Bumetanide protects focal cerebral ischemia-reperfusion injury in rat. Int J Clin Exp Pathol 7(4):1487–1494

    Google Scholar 

  39. Dousset V, Ménégon P, Rouanet F, Dumont E, Moonen CT, Caillé JM, Orgogozo JM (1999) Ischemic vascular accidents in the acute phase. J Neuroradiol 26:200–208

    CAS  PubMed  Google Scholar 

  40. Davis SM, Donnan GA, Parsons MW et al (2008) Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (epithet): a placebo-controlled randomised trial. Lancet Neurol 7:299–309

    Article  PubMed  Google Scholar 

  41. Donnan GA, Baron JC, Ma H, Davis SM (2009) Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 8:261–269

    Article  CAS  PubMed  Google Scholar 

  42. Schlaug G, Benfield A, Baird AE et al (1999) The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neurology 53:1528–1537

    Article  CAS  PubMed  Google Scholar 

  43. Nabavi DG, Leblanc LM, Baxter B, Lee DH, Fox AJ, Lownie SP et al (2001) Monitoring cerebral perfusion after subarachnoid hemorrhage using CT. Neuroradiology 43:7–16

    Article  CAS  PubMed  Google Scholar 

  44. Wintermark M, Meuli R, Browaeys P et al (2007) Comparison of CT perfusion and angiography and MRI in selecting stroke patients for acute treatment. Neurology 68:694–697

    Article  CAS  PubMed  Google Scholar 

  45. Ronning OM, Guldvog B, Stavem K (2001) The benefit of an acute stroke unit in patients with intracranial haemorrhage: a controlled trial. J Neurol Neurosurg Psychiatry 70:631–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Diringer MN, Edwards DF (2001) Admission to a neurologic–neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 29:635–640

    Article  CAS  PubMed  Google Scholar 

  47. The ATLANTIS, ECASS, NINDS rt-PA Study Group Investigators (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768–774

    Article  Google Scholar 

  48. Schellinger P, Fiebach J, Mohr A, Ringleb P, Jansen O, Hacke W (2001) Thrombolytic therapy for ischemic stroke—a review. Part I-Intravenous thrombolysis. Crit Care Med 29:1812–1818

    Article  CAS  PubMed  Google Scholar 

  49. Larrue V, von Kummer RR, Muller A, Bluhmki E (2001) Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32:438–441

    Article  CAS  PubMed  Google Scholar 

  50. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 369:275–282

    Article  CAS  PubMed  Google Scholar 

  51. Kohrmann M, Juttler E, Fiebach JB, Huttner HB, Siebert S, Schwark C et al (2006) MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 5:661–667

    Article  PubMed  Google Scholar 

  52. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, Fiehler J et al (2006) Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 h in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS and NINDS tPA trials. Stroke 37:852–858

    Article  PubMed  Google Scholar 

  53. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N (2008) Toni D; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329

    Article  CAS  PubMed  Google Scholar 

  54. Wahlgren N, Ahmed N, Dávalos A, Hacke W, Millán M, Muir K, Roine RO, Toni D (2008) Lees KR; SITS investigators. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 372:1303–1309

    Article  CAS  PubMed  Google Scholar 

  55. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G et al (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60:508–517

    Article  PubMed  Google Scholar 

  56. Furlan AJ, Eyding D, Albers GW, Al-Rawi Y, Lees KR, Rowley HA, Sachara C, Soehngen M, Warach S, Hacke W, Investigators DEDAS (2006) Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37:1227–1231

    Article  CAS  PubMed  Google Scholar 

  57. Hacke W, Albers G, Al-Rawi Y, Bogousslavsky J, Davalos A et al (2005) The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66–73

    Article  CAS  PubMed  Google Scholar 

  58. Hacke W, Furlan AJ, Al-Rawi Y, Davalos A, Fiebach JB et al (2009) Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol 8:141–150

    Article  CAS  PubMed  Google Scholar 

  59. Khaja AM, Grotta JC (2007) Established treatments for acute ischaemic stroke. Lancet 369:319–330

    Article  CAS  PubMed  Google Scholar 

  60. Badhiwala JH, Nassiri F, Alhazzani W, Selim MH, Farrokhyar F, Spears J, Kulkarni AV, Singh S et al (2015) Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. JAMA 314(17):1832–1843. doi: 10.1001/jama.2015.13767

  61. Derex L, Adeleine P, Nighoghossian N, Honnorat J, Trouillas P (2002) Factors influencing early admission in a French stroke unit. Stroke 33:153–159

    Article  PubMed  Google Scholar 

  62. Sandercock P, Gubitz G, Foley P, Counsell C (2003) Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 2:CD000029

    Google Scholar 

  63. Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE et al (2007) Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK glucose insulin in stroke trial (GIST-UK). Lancet Neurol 6:397–406

    Article  CAS  PubMed  Google Scholar 

  64. Krieger DW, De Georgia MA, Abou-Chebl A, Andrefsky JC, Sila CA, Katzan IL, Mayberg MR, Furlan AJ (2001) Cooling for acute ischemic brain damage (cool aid): an open pilot study of induced hypothermia in acute ischemic stroke. Stroke 32:1847–1854

    Article  CAS  PubMed  Google Scholar 

  65. De Georgia MA, Krieger DW, Abou-Chebl A, Devlin TG, Jauss M, Davis SM, Koroshetz WJ, Rordorf G, Warach S (2004) Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. Neurology 63:312–317

    Article  PubMed  Google Scholar 

  66. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al (2007) Guidelines for the early management of adults with ischemic stroke. Stroke 38:1655–1711

    Article  PubMed  Google Scholar 

  67. Hacke W, Kaste M, Bogousslavsky J, Brainin M, Chamorro A, Lees K et al (2003) European stroke initiative recommendations for stroke management-update 2003. Cerebrovasc Dis 16:311–337

    Article  Google Scholar 

  68. Ginsberg MD (2009) Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 40:S111–S114

    Article  PubMed  Google Scholar 

  69. Zaleska MM, Mercado ML, Chavez J, Feuerstein GZ, Pangalos MN, Wood A (2009) The development of stroke therapeutics: promising mechanisms and translational challenges. Neuropharmacology 56:329–341

    Article  CAS  PubMed  Google Scholar 

  70. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P et al (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495–505

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K et al (2009) Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40:e647–e656

    Article  CAS  PubMed  Google Scholar 

  72. Yoshimoto T, Ogawa A, Seki H, Kogure T, Suzuki J (1986) Clinical course of acute middle cerebral artery occlusion. J Neurosurg 65:326–330

    Article  CAS  PubMed  Google Scholar 

  73. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron A (1992) Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 42:289–298

    Article  CAS  PubMed  Google Scholar 

  74. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, Von Kummer R (1996) “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53:309–315

    Article  CAS  PubMed  Google Scholar 

  75. Von Kummer R, Meyding-Lamadé U, Forsting M, Rosin L, Rieke K, Hacke W (1994) Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. AJNR Am J Neuroradiol 15:9–15

    Google Scholar 

  76. Oppenheim C, Samson Y, Manaï R, Lalam T, Vandamme X, Crozier S et al (2000) Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke 31:2175–2181

    Article  CAS  PubMed  Google Scholar 

  77. Vahedi K, Hofmeijer J, Juettler E, Vicaut E, George B, Algra A et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol 6:215–222

    Article  PubMed  Google Scholar 

  78. Hornig CR, Rust DS, Busse O, Jauss M, Laun A (1994) Space-occupying cerebellar infarction. Clinical course and prognosis. Stroke 25:372–374

    Article  CAS  PubMed  Google Scholar 

  79. Cioffi FA, Bernini FP, Punzo A, D’Avanzo R (1985) Surgical management of acute cerebellar infarction. Acta Neurochir 74:105–112

    Article  CAS  PubMed  Google Scholar 

  80. Laun A, Busse O, Calatayud V, Klug N (1984) Cerebellar infarcts in the area of the supply of the PICA and their surgical treatment. Acta Neurochir 71:295–306

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d’Anesthésie-Réanimation, CHU Timone, 264 rue Saint Pierre, 13385, Marseille, Cedex, France

    Lionel Velly, D. Boumaza & Pierre Simeone

Authors
  1. Lionel Velly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Boumaza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre Simeone
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lionel Velly .

Editor information

Editors and Affiliations

  1. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Carole Ichai

  2. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Hervé Quintard

  3. Intensive Care Unit, Hôpital Pasteur 2, Centre Hospitalier Universitaire de Nice, Université Côte d’Azur, Nice, France

    Jean-Christophe Orban

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Velly, L., Boumaza, D., Simeone, P. (2018). Cerebral Ischemia: Pathophysiology, Diagnosis, and Management. In: Ichai, C., Quintard, H., Orban, JC. (eds) Metabolic Disorders and Critically Ill Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-64010-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-64010-5_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-64008-2

  • Online ISBN: 978-3-319-64010-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation